Unlocking dexmedetomidine's therapeutic potential in multiple sclerosis: Dual modulation of PI3K/Akt/BDNF and TLR4/NF-κB pathways in EAE rats.

Saved in:
Bibliographic Details
Title: Unlocking dexmedetomidine's therapeutic potential in multiple sclerosis: Dual modulation of PI3K/Akt/BDNF and TLR4/NF-κB pathways in EAE rats.
Authors: Salem MA; Department of Pharmacology, Toxicology and Biochemistry, Faculty of Pharmacy, Future University in Egypt, 90th St., 11835, Cairo, Egypt. Electronic address: mohamed.saleem@fue.edu.eg., Rabie MA; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Κasr El-Aini St., 11562, Cairo, Egypt. Electronic address: mostafa.mohammed@pharma.cu.edu.eg., El Maraghy NN; Department of Pharmacology, Toxicology and Biochemistry, Faculty of Pharmacy, Future University in Egypt, 90th St., 11835, Cairo, Egypt. Electronic address: nabila.elmaraghy@fue.edu.eg., El-Said YAM; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Κasr El-Aini St., 11562, Cairo, Egypt. Electronic address: yasmin.ahmed@pharma.cu.edu.eg., El Sayed NS; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Κasr El-Aini St., 11562, Cairo, Egypt. Electronic address: nesrine.salah@pharma.cu.edu.eg., Mansour SM; Department of Pharmacology, Toxicology and Biochemistry, Faculty of Pharmacy, Future University in Egypt, 90th St., 11835, Cairo, Egypt; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Κasr El-Aini St., 11562, Cairo, Egypt. Electronic address: suzan.mohamed@fue.edu.eg.
Source: European journal of pharmacology [Eur J Pharmacol] 2025 Dec 05; Vol. 1008, pp. 178365. Date of Electronic Publication: 2025 Nov 13.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Science Country of Publication: Netherlands NLM ID: 1254354 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0712 (Electronic) Linking ISSN: 00142999 NLM ISO Abbreviation: Eur J Pharmacol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-0712
DOI:10.1016/j.ejphar.2025.178365